T1	Intervention 17 29	rosuvastatin
T2	Intervention 79 94	type 2 diabetes
T3	Intervention 58 75	LDL-ApoB kinetics
T4	Intervention 49 53	IDL-
T5	Intervention 41 47	VLDL2-
T6	Intervention 33 38	VLDL1
T7	Intervention 97 112	AIMS/HYPOTHESIS
T8	Intervention 153 167	LDL-cholestero
T9	Intervention 170 182	rosuvastatin
T10	Intervention 224 245	plasma triacylglycero
T11	Intervention 351 366	triacylglycerol
T12	Intervention 307 322	type 2 diabetes
T13	Intervention 259 271	rosuvastatin
T14	Intervention 417 450	triacylglycerol-rich lipoproteins
T15	Intervention 459 469	2 diabetic
T16	Intervention 595 607	rosuvastatin
T17	Intervention 638 652	ype 2 diabetes
T18	Intervention 756 779	apolipoprotein B (ApoB)
T19	Intervention 791 803	lipoproteins
T20	Intervention 814 821	leucine
T21	Intervention 938 946	allocate
T22	Intervention 1107 1122	LDL-cholesterol
T23	Intervention 1059 1071	Rosuvastatin
T24	Intervention 1124 1139	triacylglycerol
T25	Intervention 1150 1154	ApoB
T26	Intervention 1212 1232	triacylglycerol-rich
T27	Intervention 1332 1343	lipoprotein
T28	Intervention 1714 1726	Rosuvastatin
T29	Intervention 2081 2091	catabolism
T30	Intervention 2152 2185	triacylglycerol-rich lipoproteins
T31	Intervention 2471 2486	atherosclerosis
T32	Intervention 2401 2434	triacylglycerol-rich lipoproteins
